Novus Acquisition & Development Corp. (OTC: NDEV), provider of a cost-saving medical plan for patients within the wellness industry, recently announced that Charlotte’s Web strain of cannabis would be available at a 30% discount to the retail price through its interactive web portal to patients enrolled in the Novus MedPlan.

“Novus MedPlan’s convenient online ordering platform provides easy access to medications and therapies, while providing a substantial discount to help make them more affordable,” said Novus Acquisition & Development Corp. CEO Frank Labrozzi. “We aim to fill the gap and bring much-needed medications and therapies to the masses in states where legal programs exist.”

Charlotte’s Web is a form of medical cannabis processed into a marijuana extract that is high in cannabidiol (“CBD”) content and lower in psychoactive tetrahydrocannabinol (“THC”) content. The strain was named after Charlotte Figi, who was diagnosed with Dravet Syndrome when she was two years old. After using the drug, she experienced a significant reduction in seizure episodes.

The strain of medical cannabis has been in the national news, since it appears to provide many benefits without the psychoactive high that’s typically associated with the negative parts of cannabis use. In fact, the Charlotte’s Web Medical Hemp Act of 2014 was introduced last year to exclude therapeutic hemp and CBD from the definition of marijuana and the Controlled Substances Act.

Shares of Novus Acquisition & Development Corp. jumped nearly 6% in early trading on Monday, April 13, 2015 following the news release.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.